Guidance from the American Diabetes Association (ADA), American Association of Clinical Endocrinology/The Obesity Society (AACE/TOS), American Gastroenterological Association (AGA), Endocrine Society, and the American Heart Association (AHA) notes that largescale trials of these agents have demonstrated sustained weight loss (roughly 10% to 20%), as well as improvements in glycemic control, blood pressure, lipid profiles, and other cardiometabolic risk factors
A recent randomized, blinded trial demonstrated that levetiracetam, fosphenytoin, and valproate have equivalent efficacy in the management of status epilepticus
Neurobion RF Forte Injection Injection is administered as an injection under the supervision of a healthcare professional
This AI-assisted tool checked spelling, grammar, punctuation, clarity, and plagiarism, suggesting corrections where needed
Patent WO2016025382 (2014)
Your provider should work with you to develop an individualized dosing and frequency schedule that works for you